EE05799B1 - Hüpokolestereemilist probiootilist mikroorganismi tüve Lactobacillus plantarum Inducia DSM 21379 sisaldav kompositsioon kasutamiseks südame-veresoonkonnahaiguste ennetamiseks - Google Patents

Hüpokolestereemilist probiootilist mikroorganismi tüve Lactobacillus plantarum Inducia DSM 21379 sisaldav kompositsioon kasutamiseks südame-veresoonkonnahaiguste ennetamiseks

Info

Publication number
EE05799B1
EE05799B1 EEP201400038A EEP201400038A EE05799B1 EE 05799 B1 EE05799 B1 EE 05799B1 EE P201400038 A EEP201400038 A EE P201400038A EE P201400038 A EEP201400038 A EE P201400038A EE 05799 B1 EE05799 B1 EE 05799B1
Authority
EE
Estonia
Prior art keywords
hypocholesterolemic
lactobacillus plantarum
cardiovascular disorders
composition
plantarum inducia
Prior art date
Application number
EEP201400038A
Other languages
English (en)
Inventor
Marika Mikelsaar
Epp Songisepp
Merle Rätsep
Pirje Hütt
Imbi Smidt
Kai Truusalu
Epp Sepp
Raik-Hiio Mikelsaar
Kalle Kilk
Jelena Stsepetova
Siiri Kõljalg
Mirjam Vallas
Original Assignee
Biocc Oü
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US14/244,284 external-priority patent/US20140335066A1/en
Application filed by Biocc Oü filed Critical Biocc Oü
Priority to EEP201800005A priority Critical patent/EE05809B1/et
Publication of EE201400038A publication Critical patent/EE201400038A/et
Publication of EE05799B1 publication Critical patent/EE05799B1/et

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus
    • C12R2001/25—Lactobacillus plantarum

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Genetics & Genomics (AREA)
  • Mycology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Nutrition Science (AREA)
  • Hematology (AREA)
  • Food Science & Technology (AREA)
  • Obesity (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Oncology (AREA)
  • Diabetes (AREA)
  • Communicable Diseases (AREA)
  • Polymers & Plastics (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

Leiutis käsitleb Lactobacillus plantarum Inducia DSM 21379 kasutamist hüpokolestereemilise, antimikroobse ja antioksüdatiivse agendina. Nimetatud tüve sisaldavatel toiduainetel ja toidulisanditel on südant kaitsev toime. Mikroorganismi L. plantarum Inducia kasutatakse kolesterooli metabolismi häirete ja südameveresoonkonnahaiguste ennetamiseks, kuna ta vähendab LDL-kolesterooli taset ja samaaegselt tõstab organismi antioksüdatiivset aktiivsust, mõjutades oksüdatiivse stressi markereid soovitud suunas - oksüdeeritud madala tihedusega lipoproteiinide (ox-LDL) tase ja oksüdatiivse stressi indeks (OSI) vähenevad.
EEP201400038A 2008-05-13 2014-10-31 Hüpokolestereemilist probiootilist mikroorganismi tüve Lactobacillus plantarum Inducia DSM 21379 sisaldav kompositsioon kasutamiseks südame-veresoonkonnahaiguste ennetamiseks EE05799B1 (et)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EEP201800005A EE05809B1 (et) 2008-05-13 2014-10-31 Probiootilist mikroorganismi tüve Lactobacillus plantarum Inducia DSM 21379 sisaldav kompositsioon kasutamiseks Clostridium difficile põhjustatud kõhulahtisuse (CDAD) riski vähendamiseks

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US14/244,284 US20140335066A1 (en) 2008-05-13 2014-04-03 Lactobacillus plantarum inducia dsm 21379 as enhancer of cellular immunity, hypocholesterolemic and anti-oxidative agent and antimicrobial agent against clostridium difficile

Publications (2)

Publication Number Publication Date
EE201400038A EE201400038A (et) 2015-11-16
EE05799B1 true EE05799B1 (et) 2017-10-16

Family

ID=51932160

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP201400038A EE05799B1 (et) 2008-05-13 2014-10-31 Hüpokolestereemilist probiootilist mikroorganismi tüve Lactobacillus plantarum Inducia DSM 21379 sisaldav kompositsioon kasutamiseks südame-veresoonkonnahaiguste ennetamiseks

Country Status (3)

Country Link
JP (1) JP2017515799A (et)
EE (1) EE05799B1 (et)
WO (1) WO2015149818A1 (et)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201519326D0 (en) 2015-11-02 2015-12-16 Optibiotix Health Ltd Composition`
GB201611782D0 (en) * 2016-07-06 2016-08-17 Optibiotix Ltd Composition
CN112823015A (zh) * 2018-08-01 2021-05-18 N.M.B.医学应用有限公司 减少卡路里的吸收和改变所消耗的营养物的营养价值的口服施用的补充剂及方法
CN109234189A (zh) * 2018-08-17 2019-01-18 甘肃普诺贝康生物科技有限责任公司 一株具有抗氧化能力的植物乳杆菌菌株bx62及其应用
WO2020171256A1 (ko) * 2019-02-21 2020-08-27 서울대학교산학협력단 클로스트리디움 디피실레(clostridium difficile) 성장 억제효과를 갖는 락토바실러스 균주
KR102365420B1 (ko) * 2022-01-04 2022-02-23 주식회사 바이오뱅크힐링 로제부리아 인테스티날리스 균주, 및 그의 유래의 소포체 및 그의 항염증 및 항균 용도
WO2023132628A1 (ko) * 2022-01-04 2023-07-13 주식회사 바이오뱅크힐링 신규 균주, 및 그의 유래의 소포체 및 그의 항염증 및 항균 용도
CN116676239B (zh) * 2023-07-26 2023-10-27 杭州微致生物科技有限公司 一种植物乳杆菌vb165及其应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2080519A1 (en) * 2008-01-15 2009-07-22 Max-Delbrück-Centrum für Molekulare Medizin (MDC) Peptides having binding affinity to an antibody which recognizes an epitope on an alpha1 loop 2 or beta 2 loop 1 of an adrenoreceptor
EE05341B1 (et) 2008-05-13 2010-08-16 O� Tervisliku Piima Biotehnoloogiate Arenduskeskus Isoleeritud mikroorganismi tvi Lactobacillus plantarum Inducia DSM 21379 kui organismi loomulikku kaitsev?imet t?stev probiootik, seda sisaldav toiduaine ja kompositsioon ning mikroorganismi kasutamine rakulist immuunsust t?stva ravimi valmistamisek
EP2311473A1 (en) 2009-10-09 2011-04-20 AB-Biotics Producciones Industriales De Microbiotas, S.L. Lactobacillus plantarum strains as probiotics

Also Published As

Publication number Publication date
WO2015149818A1 (en) 2015-10-08
JP2017515799A (ja) 2017-06-15
EE201400038A (et) 2015-11-16

Similar Documents

Publication Publication Date Title
EE05799B1 (et) Hüpokolestereemilist probiootilist mikroorganismi tüve Lactobacillus plantarum Inducia DSM 21379 sisaldav kompositsioon kasutamiseks südame-veresoonkonnahaiguste ennetamiseks
MX346458B (es) Composicion probiotica para la salud bucal.
MY160508A (en) Lactobacillus plantarum strains as hypocholesterolemic agents
MX355955B (es) Efecto antimicrobiano sinergico.
IN2012DN01638A (et)
WO2019066599A3 (ko) 신규 유산균 및 이의 용도
MY156849A (en) Novel lactobacillus plantarum and composition comprising the same
PL2288360T3 (pl) Izolowany szczep Lactobacillus plantarum Inducia dsm 21379 jako probiotyk wzmacniający naturalną odporność oraz zawierające go produkty spożywcze i preparaty medyczne
UA107711C2 (en) Use of lactobacilli inhibiting gas producing coliform bacteria isolated from infants affected by colic
RS54478B1 (en) LACTOBACILLUS PLANTARUM MCC1 DSM 23881 ISOLATED MICRO-ORGANISM AND ITS USE
PH12018550110A1 (en) Novel probiotic bacterial strain of lactobacillus plantarum and compositions and uses thereof in the treatment of inflammation
TN2016000435A1 (en) Novel macrocyclic compounds.
GB2549400A (en) Creped prebiotic tissue
WO2020091179A3 (ko) 프로바이오틱스를 유효 성분으로 포함하는 이차성 골다공증의 예방 또는 치료용 조성물
PH12017502042A1 (en) Dietary supplement
MX2016014991A (es) Composiciones que contienen acido borico y una mezcla de lactobacilos.
NZ712603A (en) Composition containing bacterium belonging to genus lactobacillus
MX2017007654A (es) Cepas probioticas con capacidad de absorber colesterol, métodos y usos de las mismas.
PH12019550231A1 (en) Probiotic bacteria preconditioned in a gos-containing medium and use thereof
IN2012DN02283A (et)
PH12015501099A1 (en) Synbiotic composition and use thereof
MX2014009957A (es) Composiciones y métodos para disminuir los conteos de microorganismos patógenos en productos alimenticios.
GEP201606589B (en) Novel bacterium and extracts of said bacterium and the use of same in dermatology
IN2014CN02038A (et)
MX2013015419A (es) Dha y epa en la reduccion de estres oxidante.

Legal Events

Date Code Title Description
HC1A Change of owner name
GB1A Change in the ownership or in the address of the owner